Contact Person : Registration Team; Last Date for the submission of abstract : Not Available ; Description : Management of hematologic malignancies, including indolent NHL, MCL, and CLL, remains a clinical challenge due to diversity in presentation, biology, and prognosis. The incorporation of monoclonal antibodies into chemotherapy regimens has..